LIVE AI research pipeline · 9 LLM agents · v0.7

AI partner for experiment design.

From a sentence, to experiments nobody’s run.

Type a scientific goal. Nine AI agents work through it with you — mapping what science knows, finding where it falls short of what your goal needs, and laying out fully-specified lab experiments that close the gap.

9reasoning agents
~10 minend-to-end
S·I·M·Tspec per experiment
/ omega-point.tracing G → G′ → RA → D → S Δ (need, known) → FQ FQ → IH → L4 → L6
SCROLL
00 / The Problem
The Status Quo

Most experiments
don’t move the field forward.

Designing experiments by intuition is expensive — and most of that cost teaches us nothing.

Bench cost
$0K+
average burn per failed experiment, end-to-end

Most hypotheses don’t pan out — and a negative result usually leaves no clear signal about what to try next.

Pipeline attrition
0%
of drug candidates fail in the clinic

It’s not a shortage of ideas. It’s the wrong experiments early — before evidence can falsify the bad ones.

Underfunded frontier
0%
of biotech funding goes to aging research

Every experiment has to count. Yet teams pick by intuition, not by which experiment maximally discriminates between competing hypotheses.

What if every experiment moved you forward — whether it confirmed or refuted the hypothesis?
01 / The Idea
The Core Idea

Match what you need
to what science knows.
Target the gap.

Most teams design experiments from what they already know. Omega-Point — an AI pipeline of nine reasoning agents — starts from what your goal requires, maps it against current scientific knowledge, then designs experiments aimed precisely at the unknown.

01
Decompose the goal into requirementsSolution-neutral Requirement Atoms — bound to a perturbation class, timescale, and failure shape.
02
Map what science actually knowsScientific Pillars across MECE research domains, including non-obvious adjacent fields.
03
Find the epistemic gapsWhere requirements have no answer. These become Frontier Questions — unanswerable by literature search.
04
Design experiments that close themCompeting hypotheses, discriminator questions, fully-specified protocols: cell line, reagents, doses, thresholds.
brain-aging example
Δ → experiment
YOUR GOAL reverse aging in the human brain 01 · WHAT YOUR GOAL NEEDS 02 · WHAT SCIENCE KNOWS Cellular waste clearance Autophagy · LC3-II ✓ MATCH Circadian alignment Clock-gene oscillation ✓ MATCH Network-scale resilience no direct readout EPISTEMIC GAP 03 / FIND THE GAP — this requirement has no answer ? FRONTIER QUESTION unanswerable from literature — needs a new experiment 3 COMPETING HYPOTHESES H1 canonical H2 heretical H3 cross-domain transfer 04 / DESIGN EXPERIMENT · fully specified SYSTEM INTERVENTION METER THRESHOLD
02 / Pipeline
9 AI Agents · Reasoning Chain

Four phases.
One reasoning chain.

The pipeline mirrors the four steps above. Each phase’s output becomes the next phase’s context. The full chain is what makes each experiment non-obvious.

I Understand the Goal → REQUIREMENTS II Map the Science → PILLARS III Find the Gaps → FRONTIER Q. IV Design Experiments → S·I·M·T LEAVES 3 STEPS 2 STEPS 1 STEP 3 STEPS
I
Phase I · Steps 01 — 03
Understand the Goal
A vague objective becomes a dense Q₀ master question, decomposed into Goal Pillars and atomized into testable Requirement Atoms — each bound to a perturbation class, timescale, and failure shape.
Output: Requirement Atoms
STEP 01
The Initiator
Transforms a vague goal into a dense, solution-neutral master question (Q₀) — system-explicit, baseline-anchored, success-criteria-driven.
STEP 02
The Immortalist Architect
Inverse Failure Analysis → 3–6 Goal Pillars + the Bridge Lexicon (Failure Channels + System Property Variables).
STEP 03
The Requirements Engineer
5–9 atomic, testable Requirement Atoms per pillar — bound to a perturbation class, timescale, and failure shape.
II
Phase II · Steps 04 — 05
Map the Science
Survey known mechanisms across MECE research domains. Each scientific pillar carries a readiness level, fragility score, and SPV capability — including non-obvious adjacent fields most researchers overlook.
Output: Scientific Pillars
STEP 04
The Domain Mapper
7–12 MECE research domains per goal — specifically including non-obvious adjacent fields conventional researchers would overlook.
STEP 05
The Domain Specialist
15–25 Scientific Pillars per domain with readiness levels (RL-1/2/3), fragility scores, and cross-domain imports.
III
Phase III · Step 06
Find the Gaps
Where does science fall short of what the goal requires? Each gap becomes a Frontier Question — unanswerable by literature search, requiring new experiments to close.
Output: Frontier Questions
STEP 06
The Strategic Science Officer
5–10 Frontier Questions targeting the Δ between Goal Requirements and Scientific Reality. Four scenario strategies: Complete Void · Fragility Trap · Proxy Mirage · Cluster Clash.
IV
Phase IV · Steps 07 — 09
Design Experiments
Each Frontier Question gets competing hypotheses (mandatory heretical + cross-domain transfer), discriminator tactical questions, and finally fully-specified S·I·M·T leaves — reagents, doses, statistical power.
Output: L6 S·I·M·T spec
STEP 07
The Instantiation Gatekeeper
4–7 competing hypotheses per frontier question — mandatory heretical + cross-domain transfer in every set.
STEP 08
The Lead Investigative Officer
Tactical questions; ≥50% are discriminators that pit hypotheses against each other.
STEP 09
The Lead Tactical Engineer
S·I·M·T leaves: System × Intervention × Meter × Threshold — reagents, doses, statistical power.
03 / Real Output Trace
One real output, in full

One goal. One chain.
One experiment that didn’t exist.

From “reverse aging in the human brain” to a dynamical-systems experiment asking whether aging itself is an attractor. Each level produced by a different agent. The leaf is only conceivable because of every level above it.

INPUT Phase I · Goal
Reverse aging in the human brain.
STEP 02 Phase I · Goal Pillar (Inverse Failure Analysis)
Cross-Regional Information Flow Recalibration & Sustained Coherence Aging fragments the symphony of the brain. Distributed networks lose their conductor — functionally interconnected regions stop synchronising oscillatory activity, individual components keep firing correctly but out of phase, and high-level cognition collapses into cacophony. The pillar reframes “aging” as a coherence-loss failure, not a parts-failure.
STEP 06 Phase III · Frontier Question (Genesis Probe)
Is aging an attractor in the brain’s control landscape? Can a brain network’s resilience to combinatorial stress be predicted by its Lyapunov exponent — a quantitative measure of how trajectories diverge in phase space? If aging is a deterministic attractor (a deep basin in the cell-fate landscape) rather than accumulated random damage, then a measurable dynamical-systems quantity should distinguish “young” from “aged” networks and predict whether perturbations escape or collapse back into the aging basin. Unanswerable by literature search.
STEP 09 Phase IV · Fully-specified experiment
Optogenetic perturbation & Lyapunov exponent measurement in cortical organoids of varying connectivity Tests whether young-like networks absorb local perturbations without losing global stability. If the macroscopic Lyapunov exponent stays bounded under stress in young organoids but diverges in aged ones, aging behaves as a fragile attractor — therapy should target the landscape geometry, not individual breakdowns.
SYSTEM
Human iPSC-derived cortical organoids expressing pan-neuronal ChR2 (pAAV-hSyn-hChR2(H134R)-EYFP, Addgene #26973). Two groups: 60-day “young-like” (n=12) and 120-day “aged-like” (n=12). Mounted on 60-well MEA plates (Axion BioSystems MEA-60W), 37°C / 5% CO₂. 3 independent batches per group.
INTERVENTION
470 nm blue LED optogenetic perturbation (Thorlabs M470L2, LEDD1B driver), 10 ms pulses at 1 Hz, sub-threshold 1 mW/mm², 5 min, applied to a single MEA quadrant. Combined with metabolic/inflammatory stress (glucose deprivation + IL-1β).
METER
60-channel MEA at 10 kHz (Axion Maestro Pro). LFP analysis pipeline (custom MATLAB / TSTOOL): attractor reconstruction, largest Lyapunov exponent, critical slowing down (variance + lag-1 autocorrelation). Computed pre- / during / post-perturbation.
THRESHOLD
“Stable” LE = <10% change from baseline. Expected effect: young-like <5% LE change; aged-like >15% under combined stress + optogenetics. Two-way ANOVA, α=0.05.
★ ★ ★ ★ Genius 8 / 10 · Feasibility 7 / 10
04 / Why ≠ ChatGPT
What makes this different

You cannot get this
from ChatGPT.

A chatbot rearranges what its training data already contains. Omega-Point derives experiments from your goal — not from text it has read. Four concrete differences.

1 · ChatGPT answers what’s already been asked.
This finds what nobody has.

Every Omega-Point Frontier Question is required to be unanswerable by literature search. If a review article already settles it, the pipeline rejects the question and generates a new one. The whole system targets the gap between what your goal demands and what published science currently delivers — that gap is where new science actually happens.

ChatGPT: “list the leading hypotheses of brain aging” → returns a textbook summary
Omega-Point: identifies the questions where no settled answer exists, then designs the experiment that would settle each one

2 · An experiment without its why
is just a guess.

Every Omega-Point experiment carries a 9-link reasoning chain: Goal → Pillar → Requirement → Domain → Science → Frontier Question → Hypothesis → Tactic → Protocol. Remove any one link and the experiment collapses into something a postdoc could pull from a review. ChatGPT skips straight to the protocol — you get the “what” with none of the “because.”

ChatGPT: “run MEA recordings on cortical organoids” → no anchor to your goal, no falsifier
Omega-Point: the same MEA readout — justified because pillar P3 requires network-level stability and this assay is the only one that discriminates hypothesis H1 from H2

3 · ChatGPT confirms.
This forces a fight.

Without adversarial design, an LLM proposes the experiments that match the dominant view — the ones that confirm what you already believe. Omega-Point structurally prevents this: every hypothesis set must include one heretical position and one cross-domain transfer, and at least half of all tactical questions must pit competing hypotheses head-to-head with a single distinguishing measurement.

ChatGPT: “test whether mTOR inhibition extends lifespan” → restates the field’s leading hypothesis
Omega-Point: same readout, three rival mechanisms run head-to-head — mTOR vs. mitochondrial uncoupling vs. proteostasis collapse — one wins, two are eliminated

4 · The 100th experiment is as
non-trivial as the first.

Ask a chatbot for 100 experiments and #50 onward is paraphrase — the same handful of ideas with reagent names swapped. Omega-Point produces hundreds of structurally distinct experiments per goal because each one requires the full 9-link chain to conceive. Every leaf ships with complete S·I·M·T (System · Intervention · Meter · Threshold/Time) and is auto-ranked by ambition and feasibility — you keep the top picks, discard the rest.

ChatGPT: first 10 experiments are fine, items 11–100 are reagent-swap rewordings of the same five ideas
Omega-Point: 100s of experiments where each one needed a different reasoning path to exist — then the AI ranks them so you don’t have to read all 100
05 / Competition
The landscape

Between literature search
and a full co-scientist. Sharp on experiment design.

A growing market of AI tools is being built for scientists. Omega-Point sits in the focused middle — sharper than search, more concrete than a general "AI scientist".

Literature layer
Elicit · Consensus

Search and synthesize the published literature. Strong at surfacing what’s already known — weak at designing new experiments end-to-end.

YOU ARE HERE
Experiment-design layer
Omega-Point

Structured falsification logic, MECE goal decomposition, hypothesis scoring, and protocol-oriented outputs you can hand straight to a bench.

Co-scientist layer
AI Scientist · Google · FutureHouse

Broad scientific assistance — the market signal is clear, but these systems aren’t optimised for the specific workflow of biotech R&D.

06 / Who It’s For
Who it’s for

Built for the people who design
experiments, not just summarize them.

The reasoning chain is the same for everyone — what changes is which leaf of the output matters most to you. Four roles where Omega-Point earns its keep:

Academia

Principal investigators & postdocs

Designing the next round of experiments where “what the lab can actually do” meets “what would move the field.” Omega-Point returns hundreds of fully-specified, ranked candidate experiments — including ones a textbook wouldn’t suggest, and the rationale chain for each.

You typereverse aging in the human brain
You get back100s of S·I·M·T protocols, each with a 9-level rationale — keep the ones that fit your equipment and timeline
Pharma & biotech R&D

Target discovery & white-space scouting

Hypothesis generation that doesn’t just repeat the literature. Frontier Questions must be unanswerable from training data — that’s where novel IP lives. Every hypothesis set is forced to include a heretical position and a cross-domain transfer.

You typefind non-amyloid mechanisms in early Alzheimer’s
You get backcompeting mechanism hypotheses, the literature gap each one targets, and the experimental discriminators that would arbitrate between them
Founders & advisors

Biotech founders, scientific advisors, due-diligence

Stress-test a scientific thesis before raising, committing, or signing off. The 9-level decomposition exposes exactly where a thesis is original versus derivative, and surfaces the foundational assumption that no one’s actually tested.

You typeextend healthy lifespan via senescent cell clearance
You get backthe failure modes the thesis must address, the gaps in supporting science, and the experiments that would actually falsify it
Grants & proposals

Grant writers & funded researchers

Argument-grade structure for a proposal. The chain — Goal → Failure Mode → Requirement → Domain → Pillar → Gap → FQ → Hypothesis → Tactical Question → Experiment — is already the spine of a defensible Aims page.

You typea direction you’re considering proposing
You get backspecific aims with built-in justification — every experiment carries the reasoning chain that explains why it matters
07 / Roadmap
Where this is going

From first pilots to a
paying R&D platform.

A 12-month plan with concrete milestones. Each phase is shaped by feedback from the previous one.

PHASE 01

Validation

May — July 2026
  • 5–10 paid pilots with academic & biotech teams
  • Outreach at Vitalist Bay — first warm intros to labs
  • 2–3 CSO testimonials on record
  • A sharp, measurable pilot success criterion
PHASE 02

Product–market fit

Aug — Nov 2026
  • PubMed integration directly inside the pipeline
  • Company knowledge-base ingest — private corpora & internal data
  • Conversational mode — driven by validation feedback
PHASE 03

Monetization

Dec 2026 — May 2027
  • $2–5K / month subscription for researchers & small labs
  • 5–10 paying seats month-on-month
  • Enterprise PoC with pharma & biotech R&D
  • ARR target: $120–600K
08 / Common Questions
Frequently asked

What people ask first.

The questions a careful researcher or R&D lead wants answered before booking the call.

Q1Is this just a wrapper around ChatGPT?

No. A plain LLM surfaces what is in its training data — Omega-Point’s Frontier Questions are constrained to be unanswerable from any literature an LLM has read. Every hypothesis set is forced to include a heretical position and a cross-domain transfer, and at least half of tactical questions must pit competing hypotheses against each other. The full breakdown is in section 04.

Q2What happens to my research goal and the output?

Your goal and the resulting experiments sit in your private workspace. Goals are not used to train any model. Sessions are stored with full JSON export, so you can pull everything out at any time. For sensitive R&D, Omega-Point runs in Docker — we can deploy it inside your environment so nothing leaves your network.

Q3Does this replace scientists?

No. It’s a creativity multiplier. Omega-Point generates the experiment space — ranked, fully specified, and auditable. Choosing which experiment to run, adapting it to your equipment, and interpreting results stays with you. Every protocol carries its full 9-level reasoning chain, so you can sanity-check the logic before spending a dollar at the bench.

Q4Which scientific domains does it cover?

Any domain where mechanism matters. The architecture is fully domain-agnostic — nothing in the nine reasoning agents is hard-coded to a specific field. We’ve verified the pipeline end-to-end across pilots as different as brain aging, plant photosynthesis, and pathogen resistance — the same machinery produced fully-specified experiments in each. The best fit is hypothesis-rich problems in the life sciences, chemistry, materials, and adjacent fields. If you can write your goal as a sentence with measurable success criteria, the pipeline runs on it.

Q5How do I know the experiments are actually feasible?

Every leaf experiment carries an explicit S·I·M·T spec: named System (cell line or organism, with source), named Intervention (compound, dose, schedule, controls), named Meter (assay, instrument, protocol) and a quantitative Threshold with statistical power. Each is scored on ambition and feasibility — avg 7.3 / 10 across all verified runs. The 9-level reasoning chain is auditable end-to-end.

Q6How does access work — and what does it cost?

We onboard testers personally. A short call to understand your research focus, then guided access to run your goal through the pipeline. Pricing is custom — per-lab arrangements for academic groups, project-based and on-prem deployment for pharma and biotech R&D teams. Start with the contact buttons in section 09.

09 / Request Access
Request access

Want to try it on
your research goal?

We onboard testers personally. Drop us a line and we’ll set up a short call to walk you through your first run.